新型コロナウイルス感染症診断の世界市場2020-2027:製品/サービス別、サンプル種類別、技術種類別(抗体検査、PCR検査)、モード別、最終用途別

◆英語タイトル:COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product & Service, By Sample Type, By Technology Type (Antibody Testing, PCR Testing), By Mode, By End-use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV007
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月3日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、新型コロナウイルス感染症診断の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、産業概要、製品/サービス別市場規模(試薬&キット、機器、サービス)、サンプル種類別市場規模(鼻咽頭スワブ、中咽頭スワブ、血液、その他)、検査種類別市場規模(分子(PCR)検査、抗原検査、抗体(血清学)検査、その他)、モード別市場規模(PoC検査、非PoC検査)、エンドユーズ別市場規模(研究所、病院、診断センター・クリニック、研究所)、地域別市場規模、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・産業概要
・新型コロナウイルス感染症診断の世界市場規模:製品/サービス別(試薬&キット、機器、サービス)
・新型コロナウイルス感染症診断の世界市場規模:サンプル種類別(鼻咽頭スワブ、中咽頭スワブ、血液、その他)
・新型コロナウイルス感染症診断の世界市場規模:検査種類別(分子(PCR)検査、抗原検査、抗体(血清学)検査、その他)
・新型コロナウイルス感染症診断の世界市場規模:モード別(PoC検査、非PoC検査)
・新型コロナウイルス感染症診断の世界市場規模:エンドユーズ別(研究所、病院、診断センター・クリニック、研究所)
・新型コロナウイルス感染症診断の世界市場規模:地域別
・競争状況
【レポートの概要】

COVID-19 Diagnostics Market Growth & Trends

The global COVID-19 diagnostics market size is expected to reach USD 24.6 billion by 2027, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.1% during the forecast period. An increase in the need for mass testing and efficiency in diagnosing the infection are key contributors to market growth. As the number of COVID-19 cases is exponentially rising, the need to develop rapid and easy-to-use diagnostic and serology tests is also increasing. This has created opportunities for emerging players and new market entries, thereby driving market revenue.

Large-scale operational entities in Sweden, such as Tele2, H&M, and Spotify are engaged in mass testing for distinguishing the staff tested positive from uninfected. In addition, key players are constantly accelerating the production and supply of diagnostic tests to keep pace with the increasing need for disease containment. For instance, in May 2020, Roche introduced an antibody test which is recognized as 100% accurate by Public Health England.

Exploring the potential of novel molecular technologies in the scaling-up of coronavirus testing is expected to offer a significant momentum to the expansion of COVID-19 diagnostics space. For instance, CRISPR-a gene editing technology-has recently made its way into the coronavirus testing market. This gene-editing technology enables detection of SARS-CoV-2 genes, via a protein, namely, CRISPR-Cas12. Acknowledging the potential of this technology in diagnosing coronavirus patients, the Food and Drug Administration (FDA) recently approved the CRISPR test for coronavirus patients in the U.S. This diagnostic kit has been approved under the provisions of emergency use.

The expanding pool of startup companies actively operating in the market for COVID-19 diagnostics is also expected to intensify market participant competition. This trend has been prominently observed in the Asia Pacific region, contributing to the fast-paced growth expected to be witnessed by this region through 2021-2027. Some of the startup manufacturers of novel COVID-19 tests include Mylab, DNA Xperts Private Limited, Rokid, Bione, and SD Biosensor.

COVID-19 Diagnostics Market Report Highlights

• Diagnostic service is estimated to capture the maximum revenue share owing to the introduction of policies and mandates to conduct testing at large scale globally

• The nasopharyngeal swabs segment is estimated to dominate the market in 2020 with a revenue share of 48%, followed by an Oropharyngeal (OP) swab. Nasopharyngeal swabs are the gold standard for COVID-19 sample collection; both oropharyngeal and nasopharyngeal swabs are largely employed in PCR testing. This has propelled the expansion of point-of-care COVID-19 testing market space, which has contributed to the segment’s fast-paced growth through 2021 to 2027

• The increasing popularity of at-home testing and handheld instruments targeted toward combating the shortage of coronavirus test kits has been witnessed. This is expected to result in the lucrative growth of Point-of-Care (POC) testing during the forecast period

• Laboratories are estimated to be the key revenue contributing end-users owing to the primary role of laboratories in sample testing for suspected individuals

• Asia Pacific is projected to dominate the market for COVID-19 diagnostics in 2020 with a revenue share of around 37% and is expected to maintain this dominance during the forecast period. This is attributed to the robust funding for fast-track studies pertaining to clinical validation of rapid testing as well as the rapid launch of novel products. Robust government initiatives aimed at increasing the number of operational laboratories dedicated to coronavirus testing across Asian countries are set to propel the market growth

【レポートの目次】

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.6.2.2 revenue modeling
1.6.2.3 Workflow mapping of covid-19 diagnostics
1.7 List of Secondary Sources
1.8 List of Primary Sources
Chapter 2 Executive Summary
2.1 COVID-19 Diagnostics Market: Market Outlook
2.1.1 Market Summary
2.2 COVID-19 Diagnostics Market: Market Segmentation
2.3 COVID-19 Diagnostics Market: Competitive Insights
Chapter 3 Industry Outlook
3.1 Parent Market
3.2 Penetration & Growth Prospect Mapping for Technology, 2020
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increase in the incidence of coronavirus globally
3.3.1.1.1 North America
3.3.1.1.2 Europe
3.3.1.1.3 Asia Pacific
3.3.1.1.4 Latin America
3.3.1.1.5 Middle East and Africa
3.3.1.2 Increasing product approvals by regulatory agencies
3.3.1.3 Government initiatives toward mass testing
3.3.1.4 Paradigm shift toward POC testing
3.3.2 Market restraint analysis
3.3.2.1 Limited testing capacity
3.3.2.2 Low demand due to supply ratio of COVID-19 reagents
3.3.3 Market opportunity analysis
3.3.3.1 Potential emerging markets
3.3.3.2 Favorable riembursement scenario
3.3.3.3 Increasing penetration of telehealth in diagnosis of Covid-19
3.3.4 Market Challenge analysis
3.3.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
3.4 COVID-19 Diagnostics Market – Porter’s Analysis
3.4.1 Porter’s Analysis
3.4.1.1 Competitive Rivalry – High
3.4.1.2 Threat of New Entrants – MoDERATE
3.4.1.3 Threat of Substitutes – Low
3.4.1.4 Bargaining Power of Suppliers – Moderate
3.4.1.5 Bargaining Power of Buyers – LoW
3.5 COVID-19 Diagnostics Market – SWOT Analysis
3.5.1 Political and Legal
3.5.1.1 Strengths
3.5.1.2 Weaknesses
3.5.1.3 Opportunities
3.5.1.4 Threats
3.5.2 Economic
3.5.2.1 Strengths
3.5.2.2 Weakness
3.5.2.3 Opportunity
3.5.2.4 Threat
3.5.3 Technological
3.5.3.1 Strengths
3.5.3.2 Weakness
3.5.3.3 Opportunity
3.5.3.4 Threat
3.6 COVID-19 Diagnostics: Company Position Analysis
3.7 COVID-19 Diagnostics: Healthcare Spending and Funding Scenario in Different Countries
3.7.1 U.S.
3.7.2 China
3.7.3 Brazil
3.7.4 Germany
3.7.5 Others
3.8 COVID-19 Diagnostics Market – Regulatory Framework
3.9 Effect on Swabs Market
3.9.1 Production shortage for viral transport media
3.9.2 Companies Leading The Viral Transport Media Market
3.9.2.1 Copan Diagnostics
3.9.2.2 Puritan Medical Products
3.9.2.3 Becton, Dickinson And Company (BD)
3.9.2.4 Thermo Fisher Scientific
3.9.2.5 Other Emerging Companies
Chapter 4 Product & Service Business Analysis
4.1 Reagents & Kits
4.1.1 Global COVID-19 Diagnostics reagents & kits market, 2020 – 2027 (USD Million)
4.2 Instruments
4.2.1 Global COVID-19 Diagnostics Instruments market, 2020 – 2027 (USD Million)
4.3 Service
4.3.1 Global COVID-19 Diagnostic services market, 2020 – 2027 (USD Million)
Chapter 5 SAMPLE TYPE Business Analysis
5.1 COVID-19 Diagnostics Market: Sample Type Movement Analysis
5.2 Nasopharyngeal Swabs
5.2.1 Global COVID-19 Diagnostics nasopharyngeal swabs market, 2020 – 2027 (USD Million)
5.3 Oropharyngeal Swabs
5.3.1 Global COVID-19 Diagnostics oropharyngeal swabs market, 2020 – 2027 (USD Million)
5.4 Blood
5.4.1 Global COVID-19 Diagnostics blood market, 2020 – 2027 (USD Million)
5.5 Others
5.5.1 Global COVID-19 Diagnostics other SAmples market, 2020 – 2027 (USD Million)
Chapter 6 Test Type Business Analysis
6.1 COVID-19 Diagnostics Market: Test Type Movement Analysis
6.2 Molecular (PCR) Testing
6.2.1 Global COVID-19 molecular (PCR) testing market, 2020 – 2027 (USD Million)
6.3 Antigen-based Testing
6.3.1 Global COVID-19 antigen-based testing market, 2020 – 2027 (USD Million)
6.4 Antibody (Serology) Testing
6.4.1 Global COVID-19 Diagnostics antibody (Serology) testing market, 2020 – 2027 (USD Million)
6.5 Other Tests
6.5.1 Global COVID-19 other tests market, 2020 – 2027 (USD Million)
Chapter 7 Mode Business Analysis
7.1 COVID-19 Diagnostics Market: Mode Movement Analysis
7.2 Point-of-Care (PoC) Testing
7.2.1 Global COVID-19 Point-of-Care (PoC) testing market, 2020 – 2027 (USD Million)
7.3 Non Point-of-Care (Non-PoC) Testing
7.3.1 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 – 2027 (USD Million)
Chapter 8 End-use Business Analysis
8.1 COVID-19 Diagnostics Market: End-use Movement Analysis
8.2 Laboratories
8.2.1 Global laboratories-based COVID-19 Diagnostics market, 2020 – 2027 (USD Million)
8.3 Hospitals
8.3.1 Global COVID-19 Diagnostics market, 2020 – 2027 (USD Million)
8.4 Diagnostic Centers and Clinics
8.4.1 Global diagnostic centers and clinics-based COVID-19 Diagnostics market, 2020 – 2027 (USD Million)
8.5 Research Institutes
8.5.1 Global research institutes-based COVID-19 Diagnostics market, 2020 – 2027 (USD Million)
Chapter 9 Regional Business Analysis
9.1 COVID-19 Diagnostics Market: Regional Movement Analysis, 2020 & 2027
9.2 North America
9.2.1 North America COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
9.2.2 The U.S.
9.2.2.1 The U.S. COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.2.2.2 The U.S. COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.2.2.3 The U.S. COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.2.2.4 The U.S. COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.2.3 Canada
9.2.3.1 Canada COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.2.3.2 Canada COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.2.3.3 Canada COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.2.3.4 Canada COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3 Europe
9.3.1 Europe COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
9.3.2 Germany
9.3.2.1 Germany COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.2.2 Germany COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.2.3 Germany COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.2.4 Germany COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3.3 The U.K.
9.3.3.1 The U.K. COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.3.2 The U.K.COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.3.3 The U.K.COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.3.4 The U.K.COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3.4 France
9.3.4.1 France COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.4.2 France COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.4.3 France COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.4.4 France COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3.5 Italy
9.3.5.1 Italy COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.5.2 Italy COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.5.3 Italy COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.5.4 Italy COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3.6 Spain
9.3.6.1 Spain COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.6.2 Spain COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.6.3 Spain COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.6.4 Spain COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.3.7 Russia
9.3.7.1 Russia COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.3.7.2 Russia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.3.7.3 Russia COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.3.7.4 Russia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.4 Asia-Pacific
9.4.1 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
9.4.2 China
9.4.2.1 China COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.4.2.2 China COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.4.2.3 China COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.4.2.4 China COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.4.3 India
9.4.3.1 India COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.4.3.2 India COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.4.3.3 India COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.4.3.4 India COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.4.4 Japan
9.4.4.1 Japan COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.4.4.2 Japan COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.4.4.3 Japan COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.4.4.4 Japan COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.4.5.2 South Korea COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.4.5.3 South Korea COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.4.5.4 South Korea COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.4.6 Australia
9.4.6.1 Australia COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.4.6.2 Australia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.4.6.3 Australia COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.4.6.4 Australia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.5 Latin America
9.5.1 Latin America COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.5.2.2 Brazil COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.5.2.3 Brazil COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.5.2.4 Brazil COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.5.3.2 Mexico COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.5.3.3 Mexico COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.5.3.4 Mexico COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.6 The Middle East and Africa (MEA)
9.6.1 MEA COVID-19 diagnostics market estimates and forecast, 2020 – 2027 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.6.2.2 South Africa COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.6.2.3 South Africa COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.6.2.4 South Africa COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by product, 2020 – 2027 (USD Million)
9.6.3.2 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 – 2027 (USD Million)
9.6.3.3 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by technology, 2020 – 2027 (USD Million)
9.6.3.4 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 – 2027 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
10.2 Strategy Framework
10.3 Market Participation Categorization
10.4 Recent Developments & Impact Analysis, by Key Market Participants
10.5 Company Profiles
10.5.1 F. Hoffmann-La Roche AG
10.5.1.1 Company overview
10.5.1.2 Financial performance
10.5.1.3 Product benchmarking
10.5.1.4 Strategic initiatives
10.5.2 Thermo Fisher Scientific, Inc.
10.5.2.1 Company overview
10.5.2.2 Financial performance
10.5.2.3 Product benchmarking
10.5.2.4 Strategic initiatives
10.5.3 PerkinElmer, Inc.
10.5.3.1 Company overview
10.5.3.2 Financial performance
10.5.3.3 Product benchmarking
10.5.3.4 Strategic initiatives
10.5.4 1drop, Inc.
10.5.4.1 Company overview
10.5.4.2 Product benchmarking
10.5.4.3 Strategic initiatives
10.5.5 Veredus Laboratories
10.5.5.1 Company overview
10.5.5.2 Financial performance (Sekisui Chemical Co., Ltd.)
10.5.5.3 Product benchmarking
10.5.5.4 Strategic initiatives
10.5.6 ADT Biotech Sdn Bhd
10.5.6.1 Company overview
10.5.6.2 Product benchmarking
10.5.6.3 Strategic initiatives
10.5.7 altona Diagnostics GmbH
10.5.7.1 Company overview
10.5.7.2 Product benchmarking
10.5.7.3 Strategic initiatives
10.5.8 bioMérieux SA
10.5.8.1 Company overview
10.5.8.2 Financial performance
10.5.8.3 Product benchmarking
10.5.8.4 Strategic initiatives
10.5.9 Neuberg Diagnostics
10.5.9.1 Company overview
10.5.9.2 Product benchmarking
10.5.9.3 Strategic initiatives
10.5.10 Abbott Laboratories
10.5.10.1 Company overview
10.5.10.2 Financial performance
10.5.10.3 Product benchmarking
10.5.10.4 Strategic Initiatives
10.5.11 Luminex Corporation
10.5.11.1 Company overview
10.5.11.2 Financial performance
10.5.11.3 Product benchmarking
10.5.11.4 Strategic Initiatives
10.5.12 Laboratory Corporation of America Holdings
10.5.12.1 Company overview
10.5.12.2 Financial performance
10.5.12.3 Product benchmarking
10.5.12.4 Strategic Initiatives
10.5.13 Hologic Inc
10.5.13.1 Company overview
10.5.13.2 Financial performance
10.5.13.3 Product benchmarking
10.5.13.1 Strategic Initiatives
10.5.14 Quest Diagnostics, Inc.
10.5.14.1 Company overview
10.5.14.2 Financial performance
10.5.14.3 Product benchmarking
10.5.14.4 Strategic Initiatives
10.5.15 Quidel Corporation
10.5.15.1 Company overview
10.5.15.2 Financial performance
10.5.15.3 Product benchmarking
10.5.15.4 Strategic Initiatives
10.5.16 ALDATU BIOSCIENCES
10.5.16.1 Company overview
10.5.16.2 Product benchmarking
10.5.16.3 Strategic Initiatives
10.5.17 Mylab Discovery Solutions Pvt Ltd.
10.5.17.1 Company overview
10.5.17.2 Product benchmarking
10.5.17.3 Strategic Initiatives
10.5.18 Danaher Corporation
10.5.18.1 Company overview
10.5.18.2 Financial performance
10.5.18.3 Cepheid
10.5.18.3.1 Company overview
10.5.18.3.2 Product benchmarking (Cepheid)
10.5.18.3.3 Strategic Initiatives
10.5.18.4 Beckman Coulter, Inc.
10.5.18.4.1 Company overview
10.5.18.4.2 Product benchmarking (Beckman Coulter)
10.5.18.4.3 Strategic Initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Incidence rate of COVID-19 in North America
TABLE 3 Incidence rate of COVID-19 in Europe
TABLE 4 Incidence rate of COVID-19 in Asia Pacific
TABLE 5 Incidence rate of COVID-19 in Latin America
TABLE 6 Incidence rate of COVID-19 in Middle East and Africa
TABLE 7 Specimen collection and storage for COVID-19 testing
TABLE 8 Different COVID-19 diagnostic tests based on different technologies
TABLE 9 North America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 10 North America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 11 North America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 12 North America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 13 North America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 14 The U.S. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 15 The U.S. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 16 The U.S. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 17 The U.S. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 18 The U.S. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 19 Canada COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 20 Canada COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 23 Canada COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 24 Europe COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 25 Europe COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 26 Europe COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 27 Europe COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 28 Europe COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 29 Germany COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 30 Germany COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 31 Germany COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 32 Germany COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 33 Germany COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 34 The U.K.COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 35 The U.K.COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 36 The U.K.COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 37 The U.K.COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 38 The U.K.COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 39 France COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 40 France COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 41 France COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 42 France COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 43 France COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 44 Italy COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 45 Italy COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 46 Italy COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 47 Italy COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 48 Italy COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 49 Spain COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 50 Spain COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 51 Spain COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 52 Spain COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 53 Spain COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 54 Russia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 55 Russia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 56 Russia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 57 Russia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 58 Russia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 59 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 60 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 61 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 62 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 63 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 64 China COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 65 China COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 66 China COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 67 China COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 68 China COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 69 India COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 70 India COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 71 India COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 72 India COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 73 Japan COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 74 Japan COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 75 Japan COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 76 Japan COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 77 Japan COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 78 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 79 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 80 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 81 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 82 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 83 Australia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 84 Australia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 85 Australia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 86 Australia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 87 Australia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 88 Latin America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 89 Latin America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 90 Latin America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 91 Latin America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 92 Latin America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 93 Brazil COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 94 Brazil COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 95 Brazil COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 96 Brazil COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 97 Brazil COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 98 Mexico COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 99 Mexico COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 100 Mexico COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 101 Mexico COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 102 Mexico COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 103 MEA COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 104 MEA COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 105 MEA COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 106 MEA COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 107 MEA COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 108 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 109 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 110 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 111 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 112 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
TABLE 113 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
TABLE 114 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
TABLE 115 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
TABLE 116 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
TABLE 117 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market revenue modeling
FIG. 9 Market revenue modeling: Considerations
FIG. 10 Market revenue modeling: Considerations
FIG. 11 Market snapshot, 2020 (USD Million)
FIG. 12 COVID-19 diagnostics market segmentation
FIG. 13 Penetration & growth prospect mapping for technology, 2020
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Distribution of cases, as of 16th July 2020
FIG. 16 Distribution of cases, as of 4th June 2020
FIG. 17 Total number of cases in North America (1st March 2020-1st June 2020)
FIG. 18 Total number of cases in Europe (1st March 2020-1st June 2020)
FIG. 19 Total number of cases in Asia Pacific (excluding Oceania) (1st March 2020-1st June 2020)
FIG. 20 Total number of cases in Latin America countries (1st March 2020-1st June 2020)
FIG. 21 Total number of cases in South Africa (1st March 2020-1st June 2020)
FIG. 22 Market restrain relevance analysis (Current & future impact)
FIG. 23 Company Position Analysis
FIG. 24 Healthcare expenditure in China, 2013-2017
FIG. 25 Healthcare expenditure in Brazil, 2013-2017
FIG. 26 COVID-19 diagnostics market: Product & service outlook and key takeaways
FIG. 27 COVID-19 diagnostics market: Product & service movement analysis
FIG. 28 Global COVID-19 diagnostics reagents & kits market, 2020 - 2027 (USD Million)
FIG. 29 Global COVID-19 diagnostics instruments market, 2020 - 2027 (USD Million)
FIG. 30 Global COVID-19 diagnostic services market, 2020 - 2027 (USD Million)
FIG. 31 COVID-19 diagnostics market: Sample Type outlook and key takeaways
FIG. 32 COVID-19 diagnostics market: Sample type movement analysis
FIG. 33 Global COVID-19 diagnostics nasopharyngeal swabs market, 2020 - 2027 (USD Million)
FIG. 34 Global COVID-19 diagnostics oropharyngeal swabs market, 2020 - 2027 (USD Million)
FIG. 35 Global COVID-19 diagnostics blood market, 2020 - 2027 (USD Million)
FIG. 36 Global COVID-19 diagnostics other samples market, 2020 - 2027 (USD Million)
FIG. 37 COVID-19 diagnostics market: Test type outlook and key takeaways
FIG. 38 COVID-19 diagnostics market: Test type movement analysis
FIG. 39 Global COVID-19 molecular (PCR) testing market, 2020 - 2027 (USD Million)
FIG. 40 Global COVID-19 antigen-based testing market, 2020 - 2027 (USD Million)
FIG. 41 Global COVID-19 antibody (Serology) testing market, 2020 - 2027 (USD Million)
FIG. 42 Global COVID-19 diagnostics other tests market, 2020 - 2027 (USD Million)
FIG. 43 COVID-19 diagnostics market: Mode outlook and key takeaways
FIG. 44 COVID-19 diagnostics market: Mode movement analysis
FIG. 45 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2027 (USD Million)
FIG. 46 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 - 2027 (USD Million)
FIG. 47 COVID-19 diagnostics market: End-use outlook and key takeaways
FIG. 48 COVID-19 diagnostics market: End-use movement analysis
FIG. 49 Global laboratories-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
FIG. 50 Global hospitals-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
FIG. 51 Global diagnostic centers and clinics-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
FIG. 52 Global research institutes-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
FIG. 53 COVID-19 diagnostics market: Regional outlook and key takeaways
FIG. 54 COVID-19 diagnostics market: Regional movement analysis
FIG. 55 North America
FIG. 56 North America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 57 The U.S.
FIG. 58 The U.S. COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 59 Canada
FIG. 60 Canada COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 61 Europe
FIG. 62 Europe COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 63 Germany
FIG. 64 Germany COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 65 The U.K.
FIG. 66 The U.K.COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 67 France
FIG. 68 France COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 69 Italy
FIG. 70 Italy COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 71 Spain
FIG. 72 Spain COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 73 Russia
FIG. 74 Russia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 75 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 76 China
FIG. 78 China COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 79 India
FIG. 80 India COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 81 Japan
FIG. 82 Japan COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 83 South Korea
FIG. 84 South Korea COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 85 Australia
FIG. 86 Australia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 87 Latin America
FIG. 88 Latin America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 89 Brazil
FIG. 90 Brazil COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 91 Mexico
FIG. 92 Mexico COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 93 Middle East & Africa
FIG. 94 MEA COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 95 South Africa
FIG. 96 South Africa COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 97 Saudi Arabia
FIG. 98 Saudi Arabia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
FIG. 99 Competition categorization
FIG. 100 Strategy framework
FIG. 101 Market participation categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[新型コロナウイルス感染症診断の世界市場2020-2027:製品/サービス別、サンプル種類別、技術種類別(抗体検査、PCR検査)、モード別、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆